Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.USPTO gives Notice of Allowance to Kythera for ATX-101 patent
ATX-101, an injectable drug being studied for the reduction of localized fat is a proprietary formulation of deoxycholate, an endogenous compound that is present in the body to
ATX-101, an injectable drug being studied for the reduction of localized fat is a proprietary formulation of deoxycholate, an endogenous compound that is present in the body to
The collaboration signed in December 2009, has been extended to an additional year through December 2012. Initially Bristol-Myers Squibb paid NeurOp a licensing fee of $1.5m and agreed
The two randomized double-blind placebo-controlled trials Phase III efficacy trials- BLOOM-1 and BLOOM-2 enrolled 597 and 575 surgically menopausal women, respectively, for six-months of therapy. In the BLOOM-1
According to the company, the new solution provides visibility into all the complexities of patient financial clearance in a single, easy-to-use application, besides increasing efficiency and reducing errors
The Siberian Ginseng (Acanthopanax) Polysaccharide is extracted from the stem of Siberian Ginseng by proprietary extraction technology separating and extracting effective parts of the Siberian Ginseng. The powder
The 18-month randomized, parallel group, double-blind, placebo-controlled trial conducted in 512 ALS patients evaluated the efficacy and safety of olesoxime against placebo in patients treated with riluzole. Olesoxime
Kun Tuo will lay emphasis on the development of customized solutions to help local and global biopharma companies achieve registration of new medicines in China. In addition the
Under the deal, Megapharm will seek regulatory approval for Fanapt, and Vanda will supply Megapharm with Fanapt drug product for packaging and sale in Israel. Vanda CEO Mihael
MedPodium’s Nutra-Apps are small, pharmaceutically-sealed, tasteless, easy-use capsules in pocket-sized packaging, designed to promote personal health. The Neo-Energy product is a dietary supplement capsule without any sugar, calories,
The company claims that once developed and approved, ITCA 650 would be the first and only once-yearly injection-free GLP-1 therapy for the treatment of Type 2 diabetes that